Invention Grant
- Patent Title: Crystalline polymorphs of a muscarinic acetylcholine receptor agonist
-
Application No.: US16338930Application Date: 2017-10-05
-
Publication No.: US11008342B2Publication Date: 2021-05-18
- Inventor: Abraham Fisher , Nira Bar-Ner , Manfred Windisch
- Applicant: NSC Therapeutics GmbH
- Applicant Address: AT St. Radegund
- Assignee: NSC Therapeutics GmbH
- Current Assignee: NSC Therapeutics GmbH
- Current Assignee Address: AT St. Radegund
- Agency: Clark & Elbing LLP
- Agent Susan M. Michaud
- Priority: EP16192494 20161005
- International Application: PCT/EP2017/075373 WO 20171005
- International Announcement: WO2018/065529 WO 20180412
- Main IPC: C07D513/10
- IPC: C07D513/10 ; A61P27/02

Abstract:
Provided are novel crystalline forms of a spiro-compound which acts as a muscarinic acetylcholine receptor agonist. In particular, isolated crystalline polymorphs of (S)-2-ethyl-8-methyl-1-thia-4,8-diazaspiro[4.5]decane-3-one are described which have favorable properties in pharmaceutical manufacture. Also provided are methods to prepare said crystalline polymorphs, and to convert them into each other as well as methods for preparing medicaments containing the same which are suitable for use in the treatment of diseases and disorders that respond to modulation of the muscarinic acetylcholine receptor.
Public/Granted literature
- US20200040007A1 CRYSTALLINE POLYMORPHS OF A MUSCARINIC ACETYLCHOLINE RECEPTOR AGONIST Public/Granted day:2020-02-06
Information query